Results 31 to 40 of about 11,864,187 (263)

Antiviral Therapy for a Postpartum Flare in Women with Chronic HBV Infection Shortens the ALT Recovery Time and Reduces Hepatitis Re-Flare Rates within 4 years

Canadian Journal of Gastroenterology and Hepatology, 2022
Background. Few studies explored whether anti-hepatitis B virus (HBV) therapy should be initiated during postpartum hepatitis flare. Aim. This study aimed to analyze the effect of anti-HBV therapy on postpartum hepatitis flare and evaluate the prognosis ...
Min Quan, Cong Liu, Wei Li, Hui-Chun Xing   +3 more
doaj   +1 more source

Gut microbiome and metabolome signatures in liver cirrhosis-related complications [PDF]

Clinical and Molecular Hepatology
Background/Aims Shifts in the gut microbiota and metabolites are interrelated with liver cirrhosis progression and complications. However, causal relationships have not been evaluated comprehensively.
Satya Priya Sharma, Haripriya Gupta, Goo-Hyun Kwon, Sang Yoon Lee, Seol Hee Song, Jeoung Su Kim, Jeong Ha Park, Min Ju Kim, Dong-Hoon Yang, Hyunjoon Park, Sung-Min Won, Jin-Ju Jeong, Ki-Kwang Oh, Jung A Eom, Kyeong Jin Lee, Sang Jun Yoon, Young Lim Ham, Gwang Ho Baik, Dong Joon Kim, Ki Tae Suk   +19 more
doaj   +1 more source

Gut Microbiota-Related Cellular and Molecular Mechanisms in the Progression of Nonalcoholic Fatty Liver Disease

Cells, 2021
Nonalcoholic fatty liver disease (NAFLD) is one of the most common and increasing liver diseases worldwide. NAFLD is a term that involves a variety of conditions such as fatty liver, steatohepatitis, or fibrosis. Gut microbiota and its products have been
Eunju Park, Jin-Ju Jeong, Sung-Min Won, Satya Priya Sharma, Yoseph Asmelash Gebru, Raja Ganesan, Haripriya Gupta, Ki Tae Suk, Dong Joon Kim   +8 more
doaj   +1 more source

Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

Clinical Liver Disease, 2019
and Scope This guidance provides a data-supported approach to the diagnosis, staging, and treatment of patients diagnosed with hepatocellular carcinoma (HCC). A guidance document is different from a guideline.
Jorge A. Marrero, L. Kulik, C. Sirlin, Andrew X. Zhu, Richard S. Finn, Michael M Abecassis, Lewis R. Roberts, Julie K Heimbach   +7 more
semanticscholar   +1 more source

Diagnosis and Treatment of Alcohol‐Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases

Hepatology, 2020
Alcoholic liver disease (ALD) represents a spectrum of liver injury resulting from alcohol use, ranging from hepatic steatosis to more advanced forms including alcoholic hepatitis (AH), alcoholic cirrhosis (AC), and acute alcoholic hepatitis presenting ...
D. Crabb, G. Im, G. Szabo, Jessica L. Mellinger, M. Lucey   +4 more
semanticscholar   +1 more source

Liver biopsy for assessment of chronic liver diseases: a synopsis

Clinical and Experimental Medicine (Testo stampato), 2022
The world-wide increase in chronic liver disease (CLD) calls for refinement of diagnostic and prognostic measures for early and accurate disease detection and management.
A. Chowdhury, Kosha J. Mehta
semanticscholar   +1 more source

The convergent application of metabolites from Avena sativa and gut microbiota to ameliorate non-alcoholic fatty liver disease: a network pharmacology study

Journal of Translational Medicine, 2023
Background Non-alcoholic fatty liver disease (NAFLD) is a serious public health issue globally, currently, the treatment of NAFLD lies still in the labyrinth.
Ki-Kwang Oh, Sang-Jun Yoon, Su-Been Lee, Sang Youn Lee, Haripriya Gupta, Raja Ganesan, Satya Priya Sharma, Sung-Min Won, Jin-Ju Jeong, Dong Joon Kim, Ki-Tae Suk   +10 more
doaj   +1 more source

Iron and Liver Diseases [PDF]

Canadian Journal of Gastroenterology and Hepatology, 1999
A mild to moderate iron excess is found in patients with liver diseases apparently unrelated to genetic hemochromatosis. Iron appears to affect the natural history of hepatitis C virus‐related chronic liver diseases, alcoholic liver disease and nonalcoholic steatohepatitis by leading to a more severe fibrosis and thus aiding the evolution to cirrhosis ...
S.R. Fargion, M. Mattioli, A.L. Fracanzani, G. Fiorelli   +3 more
openaire   +5 more sources

Changes in Glutathione Content in Liver Diseases: An Update

Antioxidants, 2021
Glutathione (GSH), a tripeptide particularly concentrated in the liver, is the most important thiol reducing agent involved in the modulation of redox processes.
M. Vairetti, L. G. Di Pasqua, M. Cagna, P. Richelmi, A. Ferrigno, C. Berardo   +5 more
semanticscholar   +1 more source

Incidence of hepatocellular carcinoma in hepatitis C cirrhotic patients with and without HIV infection: a cohort study, 1999-2011

Annals of Hepatology, 2014
Introduction. High activity antiretroviral therapy (HAART) has allowed people infected with human immunodeficiency virus (HIV) to live longer. In the course of time, hepatocellular carcinoma (HCC) began to be found in these patients.
Nicolas Di Benedetto, Mirta Peralta, Estela Alvarez, María Teresa Schroder, Claudio Estepo, Silvia Paz, Hugo Fainboim   +6 more
doaj   +1 more source